Department of Gastroenterology and Hepatology, Academic Medical Centre, University of Amsterdam, Amsterdam, the Netherlands.
Gastrointest Endosc. 2015 Jul;82(1):122-9. doi: 10.1016/j.gie.2014.12.038. Epub 2015 Mar 24.
The adenoma detection rate (ADR) is considered the most important quality indicator for colonoscopy and varies widely among colonoscopists. It is unknown whether the ADR of gastroenterology consultants can already be predicted during their colonoscopy training.
To evaluate the ADR of fellows in gastroenterology and evaluate whether this predicts their ADR as gastroenterology consultants.
Retrospective observational study.
Academic and regional centers.
Symptomatic patients undergoing colonoscopy.
The variance in ADR among 7 gastroenterology fellows during their training (between May 2004 and March 2012) and of the same fellows after they registered as consultants (between October 2011 and April 2014) was evaluated. Multivariate logistic regression was performed to compare the highest detector (endoscopist with highest ADR) with the individual fellows and to evaluate whether an ADR of 20% or higher during the training was predictive of a high ADR as a consultant.
During training, ADRs ranged from 14% to 36% (P < .001). Compared with the highest detector, the OR for detecting an adenoma ranged from 0.64 (95% CI, 0.40-1.03) to 0.29 (95% CI, 0.17-0.48). After registration, ADR ranged from 19.8% to 40.2% (P = .066). Compared with the highest detector during consultancy, the OR ranged from 0.64 (95% CI, 0.34-1.21) to 0.26 (95% CI, 0.13-0.52). Only 2 fellows significantly improved their ADR after completing their training. An ADR lower than 20% during training was associated with a lower ADR as a consultant (OR 0.51; 95% CI, 0.30-0.87).
Retrospective study.
Variance in ADR is already present during the endoscopy training of gastroenterology fellows. Most fellows do not improve their ADR after completing their training. These findings suggest that the ADR can be predicted during colonoscopy training, and we suggest that feedback and benchmarking should be implemented early during training of fellows in an effort to improve ADR in future daily practice as a consultant.
腺瘤检出率(ADR)被认为是结肠镜检查中最重要的质量指标,在结肠镜检查医师之间差异很大。目前尚不清楚胃肠病学顾问的 ADR 是否可以在他们的结肠镜检查培训期间预测。
评估胃肠病学住院医师的 ADR,并评估其是否可以预测他们作为胃肠病学顾问的 ADR。
回顾性观察研究。
学术和区域中心。
接受结肠镜检查的有症状患者。
评估 7 名胃肠病学住院医师在培训期间(2004 年 5 月至 2012 年 3 月)和他们注册为顾问后的 ADR(2011 年 10 月至 2014 年 4 月)之间的差异。采用多变量逻辑回归比较最高检出者(ADR 最高的内镜医师)与每位住院医师,并评估培训期间 ADR 达到 20%或更高是否可以预测作为顾问时的高 ADR。
在培训期间,ADR 范围为 14%至 36%(P<0.001)。与最高检出者相比,检测到腺瘤的 OR 范围为 0.64(95%CI,0.40-1.03)至 0.29(95%CI,0.17-0.48)。注册后,ADR 范围为 19.8%至 40.2%(P=0.066)。与顾问期间的最高检出者相比,OR 范围为 0.64(95%CI,0.34-1.21)至 0.26(95%CI,0.13-0.52)。只有 2 名住院医师在完成培训后显著提高了他们的 ADR。培训期间 ADR 低于 20%与顾问时的 ADR 较低相关(OR 0.51;95%CI,0.30-0.87)。
回顾性研究。
在胃肠病学住院医师的内镜检查培训期间,ADR 差异已经存在。大多数住院医师在完成培训后不会提高他们的 ADR。这些发现表明,ADR 可以在结肠镜检查培训期间预测,我们建议在住院医师培训早期实施反馈和基准测试,以努力提高未来日常实践中作为顾问的 ADR。